Literature DB >> 23245831

Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage in cells undergoing oncogene-induced senescence.

Sudha Mannava1, Kalyana C Moparthy, Linda J Wheeler, Venkatesh Natarajan, Shoshanna N Zucker, Emily E Fink, Michael Im, Sheryl Flanagan, William C Burhans, Nathalie C Zeitouni, Donna S Shewach, Christopher K Mathews, Mikhail A Nikiforov.   

Abstract

In normal human cells, oncogene-induced senescence (OIS) depends on induction of DNA damage response. Oxidative stress and hyperreplication of genomic DNA have been proposed as major causes of DNA damage in OIS cells. Here, we report that down-regulation of deoxyribonucleoside pools is another endogenous source of DNA damage in normal human fibroblasts (NHFs) undergoing HRAS(G12V)-induced senescence. NHF-HRAS(G12V) cells underexpressed thymidylate synthase (TS) and ribonucleotide reductase (RR), two enzymes required for the entire de novo deoxyribonucleotide biosynthesis, and possessed low dNTP levels. Chromatin at the promoters of the genes encoding TS and RR was enriched with retinoblastoma tumor suppressor protein and histone H3 tri-methylated at lysine 9. Importantly, ectopic coexpression of TS and RR or addition of deoxyribonucleosides substantially suppressed DNA damage, senescence-associated phenotypes, and proliferation arrest in two types of NHF-expressing HRAS(G12V). Reciprocally, short hairpin RNA-mediated suppression of TS and RR caused DNA damage and senescence in NHFs, although less efficiently than HRAS(G12V). However, overexpression of TS and RR in quiescent NHFs did not overcome proliferation arrest, suggesting that unlike quiescence, OIS requires depletion of dNTP pools and activated DNA replication. Our data identify a previously unknown role of deoxyribonucleotides in regulation of OIS.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245831      PMCID: PMC3532713          DOI: 10.1016/j.ajpath.2012.09.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 2.  Oncogene-induced senescence: the bright and dark side of the response.

Authors:  Vassilis G Gorgoulis; Thanos D Halazonetis
Journal:  Curr Opin Cell Biol       Date:  2010-09-16       Impact factor: 8.382

3.  Hydroxyurea induces de novo copy number variants in human cells.

Authors:  Martin F Arlt; Alev Cagla Ozdemir; Shanda R Birkeland; Thomas E Wilson; Thomas W Glover
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

Review 4.  Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.

Authors:  Lars-Gunnar Larsson
Journal:  Semin Cancer Biol       Date:  2011-10-24       Impact factor: 15.707

5.  ATM phosphorylates histone H2AX in response to DNA double-strand breaks.

Authors:  S Burma; B P Chen; M Murphy; A Kurimasa; D J Chen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

Review 6.  Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.

Authors:  B Van Triest; H M Pinedo; G Giaccone; G J Peters
Journal:  Ann Oncol       Date:  2000-04       Impact factor: 32.976

Review 7.  Cellular senescence: hot or what?

Authors:  Gerard I Evan; Fabrizio d'Adda di Fagagna
Journal:  Curr Opin Genet Dev       Date:  2009-01-30       Impact factor: 5.578

8.  Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy.

Authors:  P D Boucher; L J Ostruszka; P J M Murphy; D S Shewach
Journal:  Gene Ther       Date:  2002-08       Impact factor: 5.250

9.  PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.

Authors:  S Mannava; A R Omilian; J A Wawrzyniak; E E Fink; D Zhuang; J C Miecznikowski; J R Marshall; M S Soengas; R C Sears; C D Morrison; M A Nikiforov
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

10.  MLH1 deficiency enhances tumor cell sensitivity to ganciclovir.

Authors:  J J O'Konek; P D Boucher; A A Iacco; T E Wilson; D S Shewach
Journal:  Cancer Gene Ther       Date:  2009-03-20       Impact factor: 5.987

View more
  53 in total

1.  Oncogenes create a unique landscape of fragile sites.

Authors:  Karin Miron; Tamar Golan-Lev; Raz Dvir; Eyal Ben-David; Batsheva Kerem
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

2.  Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells.

Authors:  Alireza Delfarah; Sydney Parrish; Jason A Junge; Jesse Yang; Frances Seo; Si Li; John Mac; Pin Wang; Scott E Fraser; Nicholas A Graham
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

3.  Gemcitabine sensitivity factors, hENT1 and RRM1 as potential prognostic biomarker for advanced biliary tract cancer.

Authors:  Ting Deng; Hong Pan; Rubing Han; Dingzhi Huang; Hongli Li; Likun Zhou; Xia Wang; Ming Bai; Xiang Li; Rui Liu; Shaohua Ge; Tao Ning; Le Zhang; Yi Ba
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity.

Authors:  A Bianchi-Smiraglia; J A Wawrzyniak; A Bagati; E K Marvin; J Ackroyd; S Moparthy; W Bshara; E E Fink; C E Foley; G E Morozevich; A E Berman; D S Shewach; M A Nikiforov
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

5.  ATM couples replication stress and metabolic reprogramming during cellular senescence.

Authors:  Katherine M Aird; Andrew J Worth; Nathaniel W Snyder; Joyce V Lee; Sharanya Sivanand; Qin Liu; Ian A Blair; Kathryn E Wellen; Rugang Zhang
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

6.  Complex DNA structures trigger copy number variation across the Plasmodium falciparum genome.

Authors:  Adam C Huckaby; Claire S Granum; Maureen A Carey; Karol Szlachta; Basel Al-Barghouthi; Yuh-Hwa Wang; Jennifer L Guler
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

7.  Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.

Authors:  Katherine M Aird; Hua Li; Frances Xin; Panagiotis A Konstantinopoulos; Rugang Zhang
Journal:  Cell Cycle       Date:  2013-10-29       Impact factor: 4.534

8.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

Review 9.  Controversial aspects of oncogene-induced senescence.

Authors:  Anna Bianchi-Smiraglia; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

10.  DNA replication stress-induced loss of reproductive capacity in S. cerevisiae and its inhibition by caloric restriction.

Authors:  Martin Weinberger; Belém Sampaio-Marques; Paula Ludovico; William C Burhans
Journal:  Cell Cycle       Date:  2013-03-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.